Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

Bullboard Posts

Comment by BronxBullon Mar 03, 2020 3:23pm

37 Views

Post# 30762418

RE:RE:RE:VXL gave Me Lemons Today...I made Lemonade ...

And bring it soon. El Pres said to get the lead out and get working on it asap. Better partner soon as others will be too.

Goldy63 wrote:

CORONAMAN wrote: Market cap is so much lower than the other companies that attended...if nothing else...just the networking is huge for the forward growth of the company

There I agree . Rubbing elbows with the big boys is why I see a very good possibility we get a big JV partner that can build on XVL,S platform and its a race to save lives and get that cure to market so I,m holding the rest of my stack for just that annoucment . Bring it . JMO.